Company Silk Road Medical, Inc

Equities

SILK

US82710M1009

Medical Equipment, Supplies & Distribution

Analysts' Consensus

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Ratings for Silk Road Medical, Inc

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Other Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Other stock markets 21:00:00 14/05/2024 BST			5-day change	1st Jan Change
21.09 ^USD	+1.79%		+2.58%	+71.88%

12:40am	Transcript : Silk Road Medical, Inc Presents at Bank of America Health Care Conference 2024, May-14-2024 through May-16-2024
04-30	Transcript : Silk Road Medical, Inc, Q1 2024 Earnings Call, Apr 30, 2024

Silk Road Medical, Inc. is a medical device company that is focused on reducing the risk of stroke and its impact. The Company has developed an approach for the treatment of carotid artery disease called TransCarotid Artery Revascularization (TCAR). TCAR is a clinically proven procedure combining surgical principles of neuroprotection with minimally invasive endovascular techniques to treat blockages in the carotid artery at risk of causing a stroke. Its product portfolio consists of five single-use components: ENROUTE Transcarotid Neuroprotection System, ENROUTE Transcarotid Stent System, ENHANCE Transcarotid Peripheral Access Kit, ENROUTE 0.014'' Guidewire and ENROUTE Enflate Transcarotid RX Balloon Dilation Catheter. It manufactures ENROUTE NPS and ENROUTE NPS PLUS, or its ENROUTE NPS products, at its facilities in Sunnyvale, California and Plymouth, Minnesota. These facilities provide an aggregate of over 35,000 square feet of space for its production and distribution operations.

Number of employees: 474

USD in Million	2022	Weight	2023	Weight	Delta
Transcarotid Artery Revascularization 100.0 %	139	100.0 %	177	100.0 %	+27.77%

USD in Million	2022	Weight	2023	Weight	Delta
United States 100.0 %	139	100.0 %	177	100.0 %	+27.77%

Managers	Title	Age	Since
Charles McKhann CEO	Chief Executive Officer	55	11-01
Lucas Buchanan DFI	Director of Finance/CFO	46	31/07/09
William Whealon CTO	Chief Tech/Sci/R&D Officer	-	20/09/20
Tammy Leitsinger CMP	Compliance Officer	-	31/12/16
Sumaira Macdonald CTO	Chief Tech/Sci/R&D Officer	-	12/01/14
Julia Anastas LAW	General Counsel	-	30/04/20
Frances Versprille PRN	Corporate Officer/Principal	-	-
Jeremy Wright PRN	Corporate Officer/Principal	-	30/06/15
Alison Highlander HRO	Human Resources Officer	-	31/12/16
Andrew Davis PRN	Corporate Officer/Principal	55	27/05/15

Members of the board	Title	Age	Since
Don Zurbay BRD	Director/Board Member	56	25/03/18
Kevin Ballinger BRD	Director/Board Member	51	02/12/20
Jack Lasersohn CHM	Chairman	70	31/03/07
Elizabeth Weatherman BRD	Director/Board Member	64	31/03/13
Rick Anderson BRD	Director/Board Member	63	30/09/20
Tony M. Chou FOU	Founder	63	28/02/07
Tanisha Cariño BRD	Director/Board Member	49	21/07/21
Charles McKhann CEO	Chief Executive Officer	55	11-01

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	39,443,868	37,763,394 ( 95.74 %)	0	95.74 %

Name	Equities	%	Valuation
Wasatch Advisors, Inc. 11.61 %	4,549,742	11.61 %	80 M $
Capital Research & Management Co. (World Investors) 7.573 %	2,966,730	7.573 %	52 M $
Vanguard Fiduciary Trust Co. 7.460 %	2,922,495	7.460 %	52 M $
BlackRock Advisors LLC 7.342 %	2,876,224	7.342 %	51 M $
Goldman Sachs Asset Management LP 5.133 %	2,010,983	5.133 %	35 M $
Armistice Capital LLC 4.513 %	1,768,000	4.513 %	31 M $
Morgan Stanley Investment Management, Inc. 4.407 %	1,726,408	4.407 %	30 M $
D.E. Shaw & Co., Inc. 3.839 %	1,503,752	3.839 %	27 M $
Bellevue Asset Management AG 3.665 %	1,435,682	3.665 %	25 M $
STATE STREET CORPORATION 3.347 %	1,311,341	3.347 %	23 M $

Silk Road Medical, Inc.

1213 Innsbruck Drive

94089, Sunnyvale

+408 720 9002

http://www.silkroadmed.com

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

21.09 USD

Average target price

19 USD

Spread / Average Target

-9.91%

Consensus

Estimates Revisions

Company calendar

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Medical Equipment, Supplies & Distribution

Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
SILK ROAD MEDICAL, INC	+71.88%	817M
ABBOTT LABORATORIES	-5.51%	182B
MEDTRONIC PLC	+2.33%	111B
BECTON, DICKINSON AND COMPANY	-3.62%	68.48B
DEXCOM, INC.	+1.52%	49.69B
CENCORA, INC.	+8.06%	44.46B
HOYA CORPORATION	+6.24%	40.67B
METTLER-TOLEDO INTERNATIONAL, INC.	+23.35%	31.22B
WEST PHARMACEUTICAL SERVICES, INC.	+0.67%	26.09B
TERUMO CORPORATION	+18.43%	25.32B

Other Medical Equipment, Supplies & Distribution